시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 마약 시장 보고서(2025년)
Narcotic Drugs Global Market Report 2025
상품코드 : 1693341
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,242,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,023,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,803,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

마약 시장 규모는 향후 몇 년 동안 안정적인 성장세를 보일 것으로 예상되며, 2029년에는 177억 9,000만 달러에 달할 것으로 예상되며, 연평균 4.6%의 연평균 성장률(CAGR)을 보일 것입니다. 이 예측 기간의 성장은 제네릭 의약품에 대한 수요 증가, 제약 산업의 성장, 최소침습 수술에 대한 수요 증가, 완화 치료에서 마약의 사용 증가 등에 기인합니다. 예측 기간의 주요 동향으로는 의약품 기술 혁신, 원격의료 및 원격 모니터링, 비오피오이드 대체 약물 개발, 인공지능(AI)의 신약 개발 및 신약 개발 활용 등이 있습니다.

마약 시장의 성장은 만성질환의 유병률 증가에 의해 견인될 것으로 예상됩니다. 만성질환은 3개월 이상 지속되고 시간이 지남에 따라 악화되는 질병으로 정의됩니다. 마약은 암, 만성 통증 증후군, 말기 질환, 중증 관절염으로 고통받는 환자들을 구제하고 이러한 질환을 관리하는 데 중요한 역할을 하고 있습니다. 예를 들어, 2024년 6월 영국 정부 기관인 National Health Service는 2023년 영국에서 50만 명 이상(549,000명)이 제2형 당뇨병에 걸릴 위험이 있는 것으로 확인되었다고 보고했습니다. 이에 따라 GP에 등록된 비당뇨병성 고혈당 또는 예비 당뇨병 환자 수는 총 3,615,330명으로 2022년 3,065,825명에서 20% 가까이 증가했습니다. 결과적으로 만성질환의 유병률 증가가 마약 시장의 성장을 주도하고 있습니다.

마약 시장의 성장은 처방약으로서의 오피오이드 사용 증가로 인해 큰 영향을 받을 것으로 예상됩니다. 오피오이드는 합법적인 처방약과 불법 약물을 모두 포함하는 약물군으로, 행복감, 이완감, 안정감을 유발하는 것으로 알려져 있습니다. 오피오이드는 강력한 진통 및 진정 효과로 인해 특히 다른 통증 관리 방법이 충분하지 않을 때 사용되기 때문입니다. 예를 들어, 2024년 5월 호주 정부 기관인 호주 보건 복지 연구소(Australian Institute of Health and Welfare)는 2023년 어느 날 호주(서호주 제외)에서 오피오이드 의존증으로 약물 치료를 받고 있는 사람이 있는 사람이 53,272명이라고 보고했습니다. 이처럼 처방약으로 오피오이드의 사용이 증가하고 있는 것이 마약 시장의 성장을 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

A narcotic drug is a class of substances that affect the central nervous system, inducing effects like drowsiness, pain relief, euphoria, and sometimes hallucinations. These drugs are commonly derived from the opium poppy plant but can also be synthesized.

The key types of narcotic drugs include opium, heroin, codeine, oxycodone, and others. Opium is a bitter, brownish, addictive substance derived from the dried latex of immature seed capsules of the opium poppy. These narcotics come from various sources, which can be natural, semi-synthetic, or synthetic, and are used for a range of purposes, including pain management, cough suppression, diarrhea treatment, asthma relief, and more. They are distributed through a variety of channels, including hospital pharmacies, online pharmacies, and retail pharmacies, and are utilized by diverse end-users, such as hospitals, homecare services, specialty clinics, and others.

The narcotic drugs market research report is one of a series of new reports from The Business Research Company that provides narcotic drugs market statistics, including narcotic drugs industry global market size, regional shares, competitors with a narcotic drugs market share, detailed narcotic drugs market segments, market trends and opportunities and any further data you may need to thrive in the narcotic drugs industry. This narcotic drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The narcotic drugs market size has grown steadily in recent years. It will grow from $14.26 billion in 2024 to $14.85 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to increasing medical need, growing public health concerns, increasing access to healthcare, rising prevalence of chronic pain, government initiatives to improve pain management.

The narcotic drugs market size is expected to see steady growth in the next few years. It will grow to $17.79 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to growing demand for generic narcotic drugs, growing pharmaceutical industry, growing demand for minimally invasive surgeries, increased use of narcotic drugs in palliative care. Major trends in the forecast period include pharmaceutical innovation, telemedicine and remote monitoring, development of non-opioid alternatives, use of artificial intelligence (AI) in drug discovery and development.

The growth of the narcotic drug market is anticipated to be driven by the increasing incidence of chronic diseases. Chronic diseases are defined as illnesses lasting three months or more that can worsen over time. Narcotic drugs play a crucial role in managing these conditions, offering relief for patients suffering from cancer, chronic pain syndrome, terminal illnesses, and severe arthritis. For example, in June 2024, the National Health Service, a UK-based government agency, reported that in 2023, over half a million (549,000) additional individuals in England were identified as being at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330, marking a significant increase from 3,065,825 in 2022, which is nearly a 20% rise. Consequently, the increasing prevalence of chronic diseases is driving the growth of the narcotic drug market.

The growth of the narcotic drugs market is expected to be significantly influenced by the rising use of opioids as prescription medications. Opioids are a class of drugs that encompass both legal prescriptions and illegal substances, known for inducing feelings of euphoria, relaxation, and sedation. Their increasing use in prescription medicine is a key driver of narcotic drug consumption, as opioids are valued for their powerful pain-relieving and sedative effects, particularly when other pain management methods prove inadequate. For example, in May 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that on a specific day in 2023, there were 53,272 individuals undergoing pharmacotherapy for opioid dependence in Australia (excluding Western Australia), translating to a rate of 22 clients per 10,000 people. Thus, the growing use of opioids as prescription medications is propelling the growth of the narcotic drugs market.

Prominent companies within the narcotic drug market are placing a growing emphasis on product development and innovation to offer dependable products to their customers and bolster their positions in the market. As an example, in May 2023, Indivior PLC, a pharmaceutical company headquartered in the United States, introduced OPVEE (nalmefene) nasal spray. This product serves as an opioid overdose rescue medication designed for use with natural and synthetic opioids, including substances like fentanyl. It is recommended for immediate use in the treatment of known or suspected opioid overdoses in adults and pediatric patients aged 12 and older, particularly in cases involving respiratory and central nervous system depression. This development underscores the company's commitment to addressing critical medical needs and enhancing the safety of individuals at risk of opioid overdose.

In March 2023, Indivior PLC, a pharmaceutical company based in the United States, completed its acquisition of Opiant Pharmaceuticals Inc. for a total of $145 million. This strategic acquisition is intended to bolster Indivior PLC's portfolio in the field of addiction treatment and science. It is noteworthy that this acquisition includes OPNT003, an investigational opioid overdose treatment, which is seen as a crucial addition to address the ongoing opioid overdose crisis in the United States, particularly involving potent synthetic opioids like fentanyl. Opiant Pharmaceuticals Inc., a pharmaceutical company headquartered in the United States, specializes in the manufacturing of narcotic drugs. This acquisition reflects Indivior PLC's commitment to expanding its offerings in the fight against opioid overdoses and substance use disorders.

Major companies operating in the narcotic drugs market are Pfizer Inc., Johnson and Johnson Limited, AbbVie Inc., Novartis AG, AstraZeneca PLC, Sanofi S.A., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma LP, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals, Alvogen Inc., Indivior Inc., Impax Laboratories Inc., Collegium Pharmaceutical Inc., Lannett Co Inc., Par Pharmaceutical Inc., West-Ward Pharmaceuticals Corp.

Asia-Pacific was the largest region in the narcotic drugs market in 2024. The regions covered in the narcotic drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the narcotic drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The narcotic drug market consists of sales of ketobemidone, pethidine, tolidine, and trimeperidine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Narcotic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on narcotic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for narcotic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The narcotic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Narcotic Drugs Market Characteristics

3. Narcotic Drugs Market Trends And Strategies

4. Narcotic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Narcotic Drugs Growth Analysis And Strategic Analysis Framework

6. Narcotic Drugs Market Segmentation

7. Narcotic Drugs Market Regional And Country Analysis

8. Asia-Pacific Narcotic Drugs Market

9. China Narcotic Drugs Market

10. India Narcotic Drugs Market

11. Japan Narcotic Drugs Market

12. Australia Narcotic Drugs Market

13. Indonesia Narcotic Drugs Market

14. South Korea Narcotic Drugs Market

15. Western Europe Narcotic Drugs Market

16. UK Narcotic Drugs Market

17. Germany Narcotic Drugs Market

18. France Narcotic Drugs Market

19. Italy Narcotic Drugs Market

20. Spain Narcotic Drugs Market

21. Eastern Europe Narcotic Drugs Market

22. Russia Narcotic Drugs Market

23. North America Narcotic Drugs Market

24. USA Narcotic Drugs Market

25. Canada Narcotic Drugs Market

26. South America Narcotic Drugs Market

27. Brazil Narcotic Drugs Market

28. Middle East Narcotic Drugs Market

29. Africa Narcotic Drugs Market

30. Narcotic Drugs Market Competitive Landscape And Company Profiles

31. Narcotic Drugs Market Other Major And Innovative Companies

32. Global Narcotic Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Narcotic Drugs Market

34. Recent Developments In The Narcotic Drugs Market

35. Narcotic Drugs Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기